Special Issue "COVID-19 Vaccination with Public Health Perspective: Prevention and Control Strategies"
Deadline for manuscript submissions: 31 March 2024 | Viewed by 6798
Interests: HPV; meningococcal; tick borne encephalitis vaccines
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Environmental Research and Public Health: The Impacts of Health Intervention on Cancer Epidemiology
Special Issue in Microorganisms: Influenza Prevention: Exploring the Progress and Persevering through Challenges
The dramatic and disruptive COVID-19 pandemic has caused changes to health care systems and new challenges to public health. COVID-19 vaccines first became available at the end of 2020, and since then, vaccination has been central to the pandemic response of many countries. The vaccine programme met ever-extending and unprecedented targets in order to offer COVID-19 vaccines to different age groups in a short period of time. Prevention strategies and mass immunisation campaigns have been largely implemented worldwide, and the uptake has exceeded expectations and has been higher than that of other vaccination programmes.
This Special Issue aims to focus on COVID-19 prevention and control with a particular public health perspective. Special interest lies in the analysis and descriptions of policies and strategies concerning vaccination in the context of public health, health policy, and health planning with specific focuses on local, regional, and national approaches, as well as new knowledge on vaccination and any aspect of COVID-19 prevention and control.
The topics should centre around studies related to research articles, reviews, and perspectives directly related to COVID-19 measures, including current and future avenues for the prevention of the disease.
Dr. Filippo Ansaldi
Dr. Amicizia Daniela
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- COVID-19 vaccine
- vaccination strategies
- public health
- COVID-19 prevention and control strategies
- health policy